Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Shares Outstanding (Weighted Average) (2023 - 2025)

Beta Bionics (BBNX) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $40.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 536.74% to $40.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.5 million through Dec 2025, up 536.74% year-over-year, with the annual reading at $40.5 million for FY2025, 536.74% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $40.5 million in Q4 2025 for Beta Bionics, down from $43.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $43.6 million in Q3 2025 to a low of $5.3 million in Q4 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $20.9 million across 3 years, with a median of $6.4 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 20.01% in 2024 and later surged 610.64% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $5.3 million in 2023, then grew by 20.01% to $6.4 million in 2024, then soared by 536.74% to $40.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BBNX at $40.5 million in Q4 2025, $43.6 million in Q3 2025, and $43.4 million in Q2 2025.